trofosfamide has been researched along with Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atzpodien, J; Fluck, M; Morawek, L; Reitz, M | 1 |
| Aigner, B; Becker, JC; Lingitz, H; Marterer, R; Niederkorn, A; Richtig, E; Ugurel, S | 1 |
| Andreesen, R; Bataille, F; Berand, A; Bross, K; Krause, SW; Reichle, A; Vogt, T; Wild, P | 1 |
| Mauch, C | 1 |
| Andreesen, R; Berand, A; Bröcker, EB; Coras, B; Landthaler, M; Neuber, K; Reichle, A; Schultz, E; Terheyden, P; Trefzer, U; Vogt, T | 1 |
| Enk, AH; Knop, J | 1 |
1 trial(s) available for trofosfamide and Melanoma
| Article | Year |
|---|---|
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cyclophosphamide; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lactones; Male; Melanoma; Middle Aged; Pioglitazone; Salvage Therapy; Sulfones; Thiazolidinediones | 2007 |
5 other study(ies) available for trofosfamide and Melanoma
| Article | Year |
|---|---|
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Survival Analysis; Vinblastine; Vinorelbine | 2009 |
Partial response of metastatic mucosal melanoma after palliative chemotherapy with trofosfamide: a case report.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Humans; Melanoma; Neoplasm Metastasis; Palliative Care; Paranasal Sinus Neoplasms; Pleural Neoplasms | 2013 |
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Cyclophosphamide; Female; Humans; Hypoglycemic Agents; Lactones; Male; Melanoma; Middle Aged; Pioglitazone; Sarcoma; Sulfones; Thiazolidinediones; Treatment Outcome | 2004 |
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bevacizumab; Breast Neoplasms; Busulfan; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Female; Forecasting; Humans; Male; Melanoma; Neoplasm Metastasis; Neoplasms; Prospective Studies; Quality of Life; Skin Neoplasms; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
[Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Skin Neoplasms; Treatment Outcome | 2000 |